Updated Version of this Report available here
This report will analyze the market potential for minimally-invasive and non-invasive surgery. The major factor driving market growth is the increasing demand for minimally-invasive/non-invasive heart surgery, as these are safer and cheaper than invasive techniques. Following the rising levels of beauty-consciousness, the market is also witnessing a rising demand for minimally-invasive cosmetic surgeries. The end-users of the minimally-invasive and non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. Surgical devices constitute about 69% of the entire minimally-invasive and non-invasive device market.
The existing studies and third-party market reports do not provide a comprehensive understanding of the minimally-invasive and non-invasive surgery market. The critical markets within this broader field are also not analyzed. This report analyzes seven levels of micro-markets under the identified macro-markets. Other reports cover only the products and applications under minimally invasive and non-invasive surgery; and miss out on technology and end-users, which we have covered comprehensively.
Scope of the report
The report gives a full breakdown of the entire minimally invasive and non-invasive surgery market on the basis of products, applications, technology, and end-users. The report highlights strategic issues such as tapping upcoming markets, consolidating strategies, new product development, competitive positioning, gap analysis, and the identification of opportunities and challenges. Niche opportunities are identified for both product and service sub-segments within the minimally invasive and non-invasive surgery market.
The report features more than 100 tables categorized by geography, products, applications, technologies, and end-users. Each section of the report will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. The report also profiles more than 54 key companies to give a complete insight into the competitive scenario of the entire minimally invasive and non-invasive surgery market.
What makes our reports unique?
Key questions answered
Powerful Research and analysis
The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.
As the people are demanding more convenience such as painless treatment, and less post operative stay in surgeries, the market is set to evolve as a miniature instrument based surgery in the future, which will ensure further convenience in such type of surgeries. The introduction of capsule endoscopy is one such example. The minimal invasive surgery market is evolving towards more convenience for the patients and subsequent technological advancements. This showcases the growth potential of the miniature instruments based surgeries in future.
In 2009, the global minimal invasive/ non invasive market is estimated to be approximately $16.4 billion and is expected to reach $24.4 billion by 2014 at a CAGR of 8.3%.
Major driving factors for the minimal invasive/ non invasive surgery market
Major restraints for the minimally invasive/ non invasive surgery market
Major opportunities for the minimally invasive/ non invasive surgery market lies in its huge market size and growth which is driving new entrants in the market.
In the minimally invasive product market (which includes surgical devices, monitoring and visualization system, endosurgical equipments, medical robotics, and electrosurgical equipments), medical robotics is the fastest growing segment which is expected to reach $1.1 billion by 2014 growing at a CAGR of 21.3%, while surgical device alone constitute approximately $11.3 billion in 2009, which is more than 65% of the entire market.
In the minimally invasive application market (which includes gastrointestinal surgery, gynecology surgery, urology surgery, cosmetic surgery, obesity surgery, thoracic surgery, cardiac surgery, vascular surgery, orthopaedic surgery, and other surgery), cardiac surgery forms the major share of this market with estimated annual revenue of $11.2 billion in 2009. While orthopedic surgery is the highest growing market with a CAGR of 12.9% for the period 2009 to 2014 mainly due to introduction of new technologies such as joint replacements and bio implants in such surgeries.
The report covers the following markets and their subsequent micro markets as well in detail which includes their market size, forecast up to 2014, market drivers, restraints, competitive landscape, and issued patents.
1.1. KEY TAKE AWAYS
1.2. MARKETS COVERED
1.3.1. MINIMALLY/NON-INVASIVE SURGICAL EQUIPMENT MANUFACTURING COMPANIES
1.3.2. HOSPITAL SURGICAL DEPARTMENTS AND INDIVIDUAL SURGEONS
1.3.3. OUTPATIENT SURGERY CENTERS
1.3.4. BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS
3. MARKET OVERVIEW
3.1. EVOLUTION OF THE MINIMALLY INVASIVE SURGERY MARKET
3.1.1. MINIMALLY INVASIVE SURGERY VS CONVENTIONAL OPEN SURGERY
3.2. THE FUTURE OF MINIMALLY INVASIVE SURGERY
3.3. DEFINING THE MINIMALLY INVASIVE SURGERY MARKET
3.4. DEFINING THE MINIMALLY INVASIVE PRODUCT MARKET
3.5. DEFINING THE MINIMALLY INVASIVE APPLICATION MARKET
3.6. DEFINING THE MINIMALLY INVASIVE TECHNOLOGY MARKET
3.7. DEFINING THE MINIMALLY INVASIVE END-USER MARKET
3.8. MARKET DRIVERS FOR MINIMALLY INVASIVE SURGERY MARKET
3.8.1. INCREASE IN AGING POPULATION BOOSTS THE DEMAND FOR SURGERIES
3.8.2. INCREASE IN AWARENESS AND DEMAND FOR PATIENT-FRIENDLY OPERATING METHODS
3.8.3. MINIMALLY INVASIVE SURGERY HELPS REDUCE HEALTHCARE COST
3.9. RESTRAINTS FOR THE MINIMALLY INVASIVE SURGERY MARKET
3.10.OPPORTUNITIES IN THE MINIMALLY INVASIVE SURGERY MARKET
3.10.1. HUGE MARKET SIZE ATTRACTING NEW ENTRANTS IN MINIMALLY INVASIVE MARKET
3.10.2. PHYSICIANS ARE SETTING A STRONG FOUNDATION FOR THE FUTURE OF MINIMALLY INVASIVE SURGERY MARKET
4. MINIMALLY INVASIVE PRODUCT MARKET
4.1. SURGICAL DEVICES
4.1.1. MARKET DRIVERS
188.8.131.52. INNOVATIVE MARKETING MODEL BOOSTING THE DEMAND FOR MIS INSTRUMENTS
184.108.40.206. INCREASING NUMBER OF MIS PROCEDURES IS BOOSTING THE DEMAND FOR MIS INSTRUMENTS
4.1.2. HAND INSTRUMENTS
4.1.6. POWER SURGICAL INSTRUMENTS
4.1.7. OTHER SURGICAL DEVICES
4.2. MONITORING AND VISUALIZATION SYSTEMS
4.2.1. MARKET DRIVERS
4.2.2. CAMERAS AND VIDEO SUPPORT
4.2.3. OTHER MONITORING AND VISUALIZATION MARKET
4.3. ELECTROSURGICAL AND AUXILIARY EQUIPMENT
4.3.2. OTHER MARKET
4.4. ENDOSURGICAL EQUIPMENT
4.4.1. MARKET DRIVERS
4.4.2. ENDOSCOPES AND OTHER ENDOSURGICAL EQUIPMENT
4.5. MEDICAL ROBOTICS
4.5.1. MARKET DRIVERS
220.127.116.11. IMPROVED SURGICAL RESULTS ATTRACTING MORE PATIENTS
18.104.22.168. MEDICAL ROBOTICS INCREASE HOSPITAL REVENUE
4.5.2. SURGICAL NAVIGATION SYSTEMS
4.5.3. SURGICAL ROBOTS
4.5.4. DIGITAL OPERATING ROOMS
5. MINIMALLY INVASIVE SURGERY MARKET BY APPLICATION
5.1. COSMETIC SURGERY
5.1.2. PLASTIC SURGERY
5.1.3. BREAST SURGERY
5.1.4. OBESITY SURGERY
22.214.171.124.1. INCREASING INCIDENCE OF OBESITY IS DRIVING THE BARIATRIC SURGERY MARKET
126.96.36.199.2. INCREASE IN AWARENESS OF OBESITY AS A DANGEROUS DISEASE
5.1.5. HAIR REMOVAL
188.8.131.52. DRIVERS AND RESTRAINTS
5.2. GASTROINTESTINAL SURGERY
5.2.1. MARKET DRIVERS
5.3. GYNECOLOGICAL SURGERY
5.4. UROLOGICAL SURGERY
5.5. THORACIC SURGERY
5.6. CARDIAC SURGERY
184.108.40.206. TECHNOLOGY DEVELOPMENTS ARE BOOSTING THE CARDIAC SURGERY MARKET
220.127.116.11. NEW AND IMPROVED SURGICAL PROCEDURES DRIVING THE MARKET GROWTH FOR CARDIAC SURGERY
5.6.2. ROBOT-ASSISTED CARDIAC SURGERY
5.7. VASCULAR SURGERY
5.8. ORTHOPEDIC SURGERY
5.8.1. JOINT REPLACEMENT
5.8.2. SPINAL SURGERY
5.8.3. OTHER SURGERIES
6. MINIMALLY INVASIVE SURGERY MARKET-BY TECHNOLOGY
6.1. NON-VISUAL IMAGING
6.1.1. OPTICAL IMAGING
18.104.22.168. Market Drivers
6.1.2. NON-OPTICAL IMAGING
6.1.3. HYBRID IMAGING
6.2. MEDICAL ROBOTICS
6.2.1. MARKET DRIVERS
22.214.171.124. Improved Surgical Results Attracting Patients
126.96.36.199. Cost effectiveness Attracting Medical Facilities
6.3. TRANSCATHETER SURGERY
6.3.1. PERCUTANEOUS ABLATION
6.3.2. RADIOFREQUENCY ABLATION
188.8.131.52. Market Drivers
184.108.40.206.1. Increasing Consumer Base Driving the Market Growth for RFA
220.127.116.11.2. RFA Gives More Effective Results for Treatment of Liver Tumor
18.104.22.168.3. Most Promising Nonsurgical Ablation for Breast Cancer Treatment
6.3.3. MICROWAVE ABLATION
22.214.171.124. Market Drivers
126.96.36.199.1. Microwave Ablation Takes Lesser Time for Operating Tumors
188.8.131.52.2. Microwave Ablation Involves Faster Generation of Heat
6.4. LAPAROSCOPIC SURGERY
7. MINIMALLY INVASIVE SURGERY MARKET BY END-USERS
7.1. HOSPITAL SURGICAL DEPARTMENTS
7.1.1. MARKET DRIVERS
7.2. OUTPATIENTS SURGERY CENTER
7.2.1. MARKET DRIVERS
7.3. GROUP PRACTICES
7.4. INDIVIDUAL SURGEONS
7.5. MEDICAL SCHOOLS
7.6. OTHER USERS
8. MINIMALLY INVASIVE SURGERY PATENT ANALYSIS
9. MINIMALLY INVASIVE SURGERY MARKET COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.2. STRATEGIES AND DEVELOPMENTS
9.2. AESCULAP (A SUBSIDIARY OF B. BRAUN)
9.2.2. STRATEGIES AND DEVELOPMENTS
9.3. ARTHROCARE CORP.
9.3.2. STRATEGY AND DEVELOPMENTS
9.4. BIOMET, INC.
9.5. DEPUY SPINE
9.5.2. STRATEGIES AND DEVELOPMENTS
9.6. DISC-O-TECH MEDICAL TECHNOLOGIES LTD
9.7. ALPHATEC SPINE
9.7.2. STRATEGIES AND DEVELOPMENTS
9.8. GIVEN IMAGING
9.8.2. STRATEGIES AND DEVELOPMENTS
9.9. HANSEN MEDICAL
9.9.2. STRATEGIES AND DEVELOPMENTS
9.10.2.STRATEGIES AND DEVELOPMENTS
9.11.MENTICE MEDICAL SIMULATION
9.13.2.STRATEGIES AND DEVELOPMENTS
9.14.SMITH & NEPHEW
9.14.2.STRATEGIES AND DEVELOPMENTS
9.15.2.STRATEGIES AND DEVELOPMENTS
9.17.2.STRATEGIES AND DEVELOPMENTS
9.18.2.STRATEGIES AND DEVELOPMENTS
9.19.UNITED STATES SURGICAL CORP. (A SUBSIDIARY OF COVIDIAN)
9.20.ZIMMER HOLDINGS INC.
9.21.MEDTRONIC SOFAMOR DANEK
9.22.PENTAX MEDICAL COMPANY
9.22.2.STRATEGIES AND DEVELOPMENTS
9.23.SURGICAL INNOVATIONS GROUP PLC.
9.25.BOSTON SCIENTIFIC CORPORATION
9.25.2.STRATEGIES AND DEVELOPMENTS
9.26.CHARLES RUSSELL BARD INC.
9.26.2.STRATEGIES AND DEVELOPMENTS
9.27.2.STRATEGIES AND DEVELOPMENTS
9.28.KARL STORZ ENDOSKOPE BERLIN GMBH & CO
9.29.GYRUS ACMI CORP.
9.30.COOPER SURGICAL INC.
9.30.2.STRATEGIES AND DEVELOPMENTS
9.31.CLARUS MEDICAL LLC
9.32.ETHICON ENDO-SURGERY, INC.
9.34.JOHNSON & JOHNSON INC.
9.36.INTUITIVE SURGICAL INC
List of Tables
List of figures